Risk Management of Femoral Arterial Access-Related Complications in Percutaneous Coronary Intervention

  • Gopal Dubey
  • Kamal Chitkara


Femoral vascular access related complications are associated with increased morbidity, mortality, length of stay and cost. Bleeding from a femoral arterial puncture site is the most common complication seen; however, there is heterogeneity in the definition of bleeding used in Acute Coronary Syndrome (ACS) trials. The most commonly used, the Thrombolysis in Myocardial Infarction (TIMI) criteria, divide bleeding into major (>5 g/dL decrease in the haemoglobin concentration or a ≥15 % absolute decrease in haematocrit), minor (≥3 g/dL decrease in the haemoglobin concentration or ≥10 % decrease in the haemotocrit if bleeding is observed, ≥4g/dL and ≥12 % if bleeding not seen), and minimal (any clinically overt sign of haemorrhage associated with a <3g/dL decrease in the haemoglobin concentration or <9 % decrease in the haematocrit) [5]. Similarly, there exists great variability (5–20 %) in the incidence of reported femoral vascular access complications. A preventative approach is described here.


Bleeding Femoral Puncture Haemorrhage Pseudoaneurysm 


  1. 1.
    Kugelmass AD, Cohen DJ, Brown PP, Simon AW, Becker ER, Culler SD. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol. 2006;97:322–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Jacobson KM, Long KH, McMurtry EK, Naessens JM, Rihal CS. The economic burden of complications during percutaneous coronary intervention. Qual Saf Health Care. 2007;16:154–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008;1:202–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Manoukian SV. The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk. J Invasive Cardiol. 2010;22:132–41.PubMedGoogle Scholar
  5. 5.
    Mehran S, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelbbom J, et al. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123:2736–47.CrossRefPubMedGoogle Scholar
  6. 6.
    Nasser TK, Mohler 3rd ER, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol. 1995;18:609–14.CrossRefPubMedGoogle Scholar
  7. 7.
    Garrett PD, Eckart RE, Bauch TD, Thompson CM, Stajduhar KC. Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv. 2005;65:205–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Dotter CT, Rosch J, Robinson M. Fluoroscopic guidance in femoral artery puncture. Radiology. 1978;127:266–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Lechner G, Jantsch H, Waneck R, Kretschmer G. The relationship between the common femoral artery, the inguinal crease, and the inguinal ligament: a guide to accurate angiographic puncture. Cardiovasc Intervent Radiol. 1988;11:165–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Fitts J, Ver LP, Hofmaster P, Malenka D. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol. 2008;21:273–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access with Ultrasound Trial). JACC Cardiovasc Interv. 2010;3:751–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Dudeck O, Teichgraeber U, Podrabsky P, Lopez Haenninen E, Soerensen R, Ricke J. A randomized trial assessing the value of ultrasound-guided puncture of the femoral artery for interventional investigations. Int J Cardiovasc Imaging. 2004;20:363–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Hanson JM, Atri M, Power N. Ultrasound-guided thrombin injection of iatrogenic groin pseudoaneurysm: Doppler features and technical tips. Br J Radiol. 2008;81:154–63.CrossRefPubMedGoogle Scholar
  14. 14.
    Schneider C, Malisius R, Küchler R, Lampe F, Krause K, Bahlmann E, Kuck KH. A prospective study on ultrasound-guided percutaneous thrombin injection for treatment of iatrogenic post-catheterisation femoral pseudoaneurysms. Int J Cardiol. 2009;131:356–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Schaub F, Theiss W, Heinz M, Zagel M, Schömig A. New aspects in ultrasound guided compression repair of postcatheterization femoral artery injuries. Circulation. 1994;90:1861–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Mak GY, Daly B, Chan W, Tse KK, Chung HK, Woo KS. Percutaneous treatment of post catheterization massive retroperitoneal hemorrhage. Cathet Cardiovasc Diagn. 1993;29:40–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Dabney A, Bastani B. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases. Intensive Care Med. 2001;27:1954–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Sommer C, Ferbert A. Damage to the lateral cutaneous femoral nerve after transfemoral angiography. Nervenarzt. 1992;63:633–5.PubMedGoogle Scholar
  19. 19.
    Sohail MR, Khan AH, Dr Holmes Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005;80:1011–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Nikolsky E, Mehran R, Halkin A, Mintz GS, Lasic Z, Negoita M, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200–9.PubMedGoogle Scholar
  21. 21.
    Lasic Z, Nikolsky E, Kesanakurthy S, Dangas G. Vascular closure devices: a review of their use after invasive procedures. Am J Cardiovasc Drugs. 2005;5:185–200.CrossRefPubMedGoogle Scholar
  22. 22.
    Hamel WJ. Femoral artery closure after cardiac catheterization. Crit Care Nurse. 2009;29:39–46.CrossRefPubMedGoogle Scholar
  23. 23.
    Rashid MN, Bailey SR. Percutaneous femoral access and vascular closure devices. Available at: Accessed 9 July 2012.
  24. 24.
    Rao S, Kaul P, Stouffer GA. Successful aspiration of Mynx vascular closure device sealant that embolized to the popliteal artery. J Invasive Cardiol. 2013;25:E172–4.PubMedGoogle Scholar
  25. 25.
    Gupta A, Sadiq I, Borer S. Distal embolisation from Mynx device. Conn Med. 2012;76:545–8.PubMedGoogle Scholar
  26. 26.
    Azmoon S, Pucillio AL, Aronow WS, Ebrahimi R, Vozzolo J, Rajdev A, et al. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. J Invasive Cardiol. 2010;22940:175–8.Google Scholar

Copyright information

© Springer-Verlag London 2016

Authors and Affiliations

  1. 1.Department of CardiologyRoyal Derby HospitalDerbyUK
  2. 2.Department of CardiologyRoyal Derby HospitalDerbyUK

Personalised recommendations